KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RMD) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Resmed (RMD) over the last 13 years, with Q1 2022 value amounting to $188.1 million.

  • Resmed's Shares Outstanding rose 39.98% to $188.1 million in Q1 2022 from the same period last year, while for Mar 2022 it was $188.1 million, marking a year-over-year increase of 39.98%. This contributed to the annual value of $187.5 million for FY2021, which is 40.81% up from last year.
  • Latest data reveals that Resmed reported Shares Outstanding of $188.1 million as of Q1 2022, which was up 39.98% from $188.0 million recorded in Q4 2021.
  • In the past 5 years, Resmed's Shares Outstanding ranged from a high of $188.1 million in Q1 2022 and a low of $184.1 million during Q1 2018
  • Over the past 5 years, Resmed's median Shares Outstanding value was $186.5 million (recorded in 2020), while the average stood at $186.3 million.
  • As far as peak fluctuations go, Resmed's Shares Outstanding soared by 71.14% in 2019, and later skyrocketed by 37.79% in 2021.
  • Over the past 5 years, Resmed's Shares Outstanding (Quarter) stood at $185.1 million in 2018, then increased by 0.71% to $186.4 million in 2019, then increased by 0.49% to $187.3 million in 2020, then increased by 0.38% to $188.0 million in 2021, then grew by 0.03% to $188.1 million in 2022.
  • Its Shares Outstanding was $188.1 million in Q1 2022, compared to $188.0 million in Q4 2021 and $187.5 million in Q3 2021.